Business Context and Reporting Period
This Form 8-K Current Report was filed by MacroGenics, Inc. on November 21, 2024, covering events occurring on November 18 and 19, 2024. The filing addresses significant changes in the company's senior financial leadership.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is strictly an administrative report regarding personnel changes.
Material Changes
- Resignation: Lynn Cilinski notified the company of her intention to retire as Vice President, Controller, Treasurer, and Principal Accounting Officer, effective January 2, 2025. She served the company for 21 years.
- Appointment: The Board appointed Beth Smith to succeed Ms. Cilinski in the same roles, effective January 2, 2025.
- Background: Ms. Smith has been with MacroGenics since 2013, most recently serving as Executive Director of Accounting and Assistant Controller since June 2022.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. Regarding risks and contingencies, the company stated there are no family relationships between Ms. Smith and current directors or officers, and no transactions requiring disclosure under Item 404(a) of Regulation S-K. The company noted that no material plans or contracts have been entered into with Ms. Smith regarding this promotion as of the filing date; if such arrangements are made, an amendment will be filed within four business days.
Investor Verification Checklist
- Verify the effective date of the leadership transition (January 2, 2025).
- Monitor for any future amendments to this 8-K regarding material compensation plans or contracts for the new Principal Accounting Officer.
- Confirm the continuity of financial reporting processes during the transition period between November 2024 and January 2025.